Form 4 for CRL Charles River Laboratories
Accepted 2023-12-01 00:00:00 ET · period of report 2023-11-30 · accession 0001127602-23-028591 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-12-01 | 2023-11-30 | CRL | LaPlume Joseph W | EVP, Corp Strategy, Develop | S - Sale | $197.73 | -1,850 | 23.1K | -7% | -$365.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-11-30 | S | D | 1,850 | $197.73 | 23,133 | D | — | — |